JAK-STAT Inhibition to Reduce Racial Disparities in Kidney Disease
Description: Project Narrative The proposed research is relevant to public health because discovery of therapy for APOL1-associated kidney disease will reduce the incidence of end stage kidney disease and associated costs and mortality, and mitigate racial disparities in kidney health in the U.S., which is within the mission of NIDDK.
Funding type: research
Funder scheme: R01
Start date: 2021-09-20
End date: 2027-05-31
Investigator: OPEYEMI AYODEJI OLABISI
Institution: DUKE UNIVERSITY
Funded outputs count: 16
Funder award ID: R01MD016401
OpenAlex ID: G9000916590